214 related articles for article (PubMed ID: 15567446)
1. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Crowther MA; Wisloff F
Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
Crowther MA
Thromb Res; 2004; 114(5-6):443-6. PubMed ID: 15507276
[TBL] [Abstract][Full Text] [Related]
3. How much warfarin is enough in APS related thrombosis?
Erkan D; Lockshin MD
Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies in critical illness.
Dentali F; Crowther M
Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
[TBL] [Abstract][Full Text] [Related]
6. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
7. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
Brunner HI; Chan WS; Ginsberg JS; Feldman BM
J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
[TBL] [Abstract][Full Text] [Related]
8. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
[TBL] [Abstract][Full Text] [Related]
9. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
10. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
11. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
[TBL] [Abstract][Full Text] [Related]
12. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
13. Management of antiphospholipid antibody syndrome: a systematic review.
Lim W; Crowther MA; Eikelboom JW
JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
[TBL] [Abstract][Full Text] [Related]
14. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome.
Erkan D; Lockshin MD
Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
[TBL] [Abstract][Full Text] [Related]
17. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
19. Low intensity warfarin: is it clinically useful in venous thromboembolism management?
Bauer KA
Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620
[TBL] [Abstract][Full Text] [Related]
20. Management of the neurological manifestations of APS--what do the trials tell us?
Brey RL
Thromb Res; 2004; 114(5-6):489-99. PubMed ID: 15507283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
